Artículo del Dr. Ignacio Rodriguez Uña
Tercer Premio THEA-S.E.G. de Investigación en Oftalmología 2017 a las mejores publicaciones en Glaucoma en el XII Congreso de la Sociedad Española de Glaucoma en Valencia.
SHOULD ONE INVEST IN BASIC AND TRANSLATIONAL RESEARCH?
The activity of the Fundación de Investigación Oftlamológica (FIO – Eye Research Foundation), a private entity devoted to the study of the basis of the diseases that compromise vision (…)
“WHEN THE EYE LACKS WATER” (EL MUNDO)
Dr Jesús Merayo, coordinator of the Unit of Eye Surface and Inflammation at the Institute, answers to the questions of El Mundo.
“DOING IT WELL DOESN’T CUT IT, IT HAS TO BE BETTER: EXCELLENCE IS THE KEY” (EL COMERCIO)
Luis Fernández-Vega, Medical Director at the Institute, warns about the cutbacks in investigation and defends the power of the “marca Asturias” (Asturian brand).
LUIS DEL OLMO INTERVIEWS PROF LUIS FERNÁNDEZ-VEGA IN “EL DÍA MENOS PENSADO”
The interview will take place on Friday 14th June at 11:00 h. in Radio Nacional de España.
“MOBILE, TABLET OR E-BOOK: HOW TO AVOID EYESIGHT PROBLEMS” (EFE SALUD)
To blink, to choose the right contrast and font size or to have a good focal illumination are some of the advices given by ophthalmologist Luis Fernández-Vega to avoid eyesight problems caused by reading in electronic devices.
“THE NEW ERA OF KERATOCONUS” (LA NUEVA ESPAÑA)
The last advances have enabled the development of efficient surgical techniques for the treatment of keratoconus aiming to delay or even avoid its progression.
THE INSTITUTE LEADS A PROJECT TO CREATE ARTIFICIAL CORNEAS
The aim of the project is to perform regenerative medicine in the eye surface and in the cornea from silk derivatives.
“TECHNOLOGY HELPS, BUT THE HAND OF THE OPHTHALMOLOGIST IS PARAMOUNT” (DIARIO INFORMACIÓN)
Fernández-Vega claims that in these 15 years FACO has become one of the most important conferences in Spain. “It’s the first and it sets the trend for the year”, he said.
“ALSA AND THE INSTITUTO FERNÁNDEZ-VEGA STRENGTHEN THEIR COLLABORATION” (LA NUEVA ESPAÑA)
Both have established an advantageous “symbiosis” and offer special conditions to patients and employees.
